Insider Transactions in Q3 2022 at Nurix Therapeutics, Inc. (NRIX)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 01
2022
|
Christine Ring Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
712
-13.37%
|
$10,680
$15.67 P/Share
|
|
Aug 01
2022
|
Stefani Wolff EVP and COO |
SELL
Open market or private sale
|
Direct |
356
-22.33%
|
$5,340
$15.67 P/Share
|
|
Aug 01
2022
|
Hans Van Houte Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
752
-1.02%
|
$11,280
$15.67 P/Share
|
|
Aug 01
2022
|
Gwenn Hansen Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,186
-5.83%
|
$17,790
$15.67 P/Share
|
|
Jul 30
2022
|
Christine Ring Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,924
+26.53%
|
-
|
|
Jul 30
2022
|
Stefani Wolff EVP and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
962
+37.64%
|
-
|
|
Jul 30
2022
|
Hans Van Houte Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,886
+3.78%
|
-
|
|
Jul 30
2022
|
Gwenn Hansen Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,207
+13.61%
|
-
|